Direct Switch from Tiotropium to Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease Patients in Korea

BACKGROUND: Many chronic obstructive pulmonary disease (COPD) patients receiving monotherapy continue to experience symptoms, exacerbations and poor quality of life. This study aimed to assess the efficacy and safety of direct switch from once-daily tiotropium (TIO) 18 μg to indacaterol/glycopyrroni...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sang Haak, Rhee, Chin Kook, Yoo, Kwangha, Park, Jeong Woong, Yong, Suk Joong, Kim, Jusang, Lee, Taehoon, Lim, Seong Yong, Lee, Ji-Hyun, Park, Hye Yun, Moon, Minyoung, Jung, Ki-Suck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010420/
https://www.ncbi.nlm.nih.gov/pubmed/33352035
http://dx.doi.org/10.4046/trd.2020.0109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010420/
https://www.ncbi.nlm.nih.gov/pubmed/33352035
http://dx.doi.org/10.4046/trd.2020.0109

Ejemplares similares